← Leaderboards
Max Peter Kullberg
University Of Alaska Anchorage
$716,269
Attributed
$937,167
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $441.8K · FY2018–22$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$937,167 · 1
By mechanism
R15$937,167 · 1
Top collaborators
- Holly A Martinson1 shared
Most similar at University Of Alaska Anchorage
Same institution · by research overlap
- Holly A Martinson$435,538
- Tracey Kathleen Burke$214,640
- Betty Buchan Monsour$8,000
Others in their field
Other Emerging Leaders on “Liposomes”
- Steven M Cohen · Drug Delivery Company, Llc, The$5,149,812
- Jeffrey Benner · Drug Delivery Company, Llc, The$5,149,812
- Gaurav Sahay · Oregon State University$3,918,234
- Mikyung Kim · Dana-Farber Cancer Inst$3,787,262
- Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med$3,259,509
- Richard R. Bouchard · University Of Tx Md Anderson Can Ctr$3,068,177
Research focus
LiposomesNovel StrategiesComplementLiposomal DeliveryMalignant NeoplasmsMelanomaBaseAgonistEncapsulatedImmunotherapyMacrophageB-LymphocytesAnti-Tumor Immune ResponseMediatingCancer ImmunotherapyCancer ModelCancer PatientAntigen-Presenting CellsAntigensDendritic CellsBiomedical ResearchImmune ResponseAntigen PresentationPathogen
Grant awards (3)
Enhancing Tumor Antigen Presentation with Complement Targeted Nanoparticles$441,796
R15 · FY2022 · CA · contact PI
Diversity Supplement for C3-liposome based cancer immunotherapy$67,006
R15 · FY2020 · CA · contact PI
Enhancing Tumor Antigen Presentation with Complement Targeted Nanoparticles$428,365
R15 · FY2018 · CA · contact PI